Antibodies — Editors

Journal Contact

Antibodies Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Dr. Dimiter S. Dimitrov
National Cancer Institute Building 567, Room 152, Frederick, MD 21702, USA
Interests: therapeutic antibodies; human antibodies and their interactions; vaccine immunogens; molecular engineering; screening and sequencing methodologies; therapeutic proteins; cancer; infectious diseases
Prof. Dr. Tomohiro Kurosaki *
Former Editor-in-Chief
1 1 World Premier Institute, Immunology Frontier Research Center 9F, Integrated Life Science Building, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan
2 RIKEN Research Center for Allergy and Immunology, Kanagawa, Japan
Interests: B lymphocyte; plasma cell; antibody; differentiation; signaling; immunological memory
* Founding Editor-in-Chief and Editor-in-Chief up to July 2014.

Prof. Dr. Scott Alper
Integrated Department of Immunology and Integrated Center for Genes, Environment and Health, National Jewish Health and University of Colorado School of Medicine, 1400 Jackson St., Denver, CO 80206, USA
Interests: basic immunology; inflammation; innate immunity; molecular genetics
Prof. Dr. Patrick A. Baeuerle
AMGEN Research (Munich) GmbH, Staffelseestr. 2, 81477 Munich, Germany
Interests: bispecific antibodies; T cells; antibody drug conjugates; Fc-engineered antibodies; cancer therapy; antibody targets
Contribution: Special Issue: Modes of Antibody Action for Cancer Therapy
Dr. Jagadeesh Bayry
Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM Unité 872, Equipe 16  " Immunopathology and therapeutic immunointervention", Centre de Recherche des Cordeliers, 15 Rue de l'Ecole de Médecine, 75006 PARIS, France
Interests: immunology; autoimmunity; host-pathogen interaction; therapy
Contribution: In other journals:
Special Issue: Monoclonal Antibody
Dr. Thomas Böldicke
Recombinant Protein Expression/Intrabody Unit, Helmholtz-Centre for Infection Research, Inhoffenstraße 7, D 38124 Braunschweig, Germany
Interests: antibody engineering; selection of human antibodies; cancer therapy; intracellular antibodies
Contribution: Special Issue: Antibody Engineering
Prof. Dr. John C. Cambier
Integrated Department of Immunology, University of Colorado Denver School of Medicine and National Jewish Health, Denver, CO 80206, USA
Interests: autoimmunity; B cell anergy; antigen receptors and signaling; Fc receptors
Dr. Raphael Clynes
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Interests: antibodies; therapeutic antibodies in cancer; autoantibodies and inflammation; Fc receptor function on dendritic cells
Prof. Dr. António Coutinho
Instituto Gulbenkian de Ciência, Apartado 14, P-2781-901 Oeiras, Portugal
Interests: immunology, lymphocyte activation, natural antibodies, tolerance and autoimmune diseases, auto-organization and networks
Prof. Dr. Mark Cragg
Antibody and Vaccine Group Faculty of Medicine Cancer Sciences University of Southampton UK
Interests: immunotherapy; monoclonal antibody effector mechanisms; lymphoma; leukaemia; FcR\'s
Prof. Dr. Martin Glennie
Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Tremona Road, Southampton SO16 6YD, UK
Interests: cancer immunotherapy; antibody structure and function; monoclonal antibody engineering; immunomodulating antibodies
Prof. Dr. Rui Gong
Antibody Engineering Group, Center for Emerging Infectious Diseases, CAS Key Laboratory of Special, Pathogens and Biosafety, Wuhan Institute of Virology (WIV), Chinese Academy of Sciences (CAS), No.44 Xiao Hong Shan, Wuhan, Hubei 430071, China
Interests: phage display, yeast display, B cell immortalization; vaccine design by epitope analysis; Fc fragments
Prof. Dr. Nicola Harris
Laboratory of Intestinal Immunology, Swiss Vaccine Research Institute &Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, EPFL-SV-GHI, Station 19, CH-1015 Lausanne, Switzerland
Interests: ADCC; polyclonal antibodies; granulocytes; infectious disease; vaccines; cytokines; T cells; B cells
Prof. Dr. Mitchell Ho
National Cancer Institute, Building 37, Room 5002C, 37 Convent Drive, MSC 4264 Bethesda, MD 20892-4264, USA
Interests: cancer immunotherapy; antibody engineering; therapeutic antibodies; molecular targets; human monoclonal antibodies; single-domain antibodies; phage display; mammalian cell display; cancer therapeutic targets; tumor spheroid models; liver cancer; hepatocellular carcinoma; mesothelioma
Prof. Dr. Chaim O. Jacob
Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR #705, Los Angeles CA 90033, USA
Interests: immunology; autoimmunity; host-pathogen interaction; therapy
Dr. Cecile King
Immunology Program, The Garvan Institute of Medical Research, 384 Victoria Street Darlinghurst, NSW, 2010, Australia
Interests: ADCC; neutralizing antibodies; cytokines; IL-21; IL-22; T cells, B cells; autoimmune disease; mucosal autoimmunity
Contribution: Special Issue: Cytokine Growth Factor Antibodies in Immunotherapy
Prof. Dr. Roland Kontermann
Institut für Zellbiologie und Immunologie, Universität Stuttgart, Allmandring 31, D-70569 Stuttgart, Germany
Interests: bifunctional antibody fusion proteins; half-life extension strategies; targeted nanoparticulate drug delivery systems
Contribution: Special Issue: Bispecific Antibodies for Dual Targeting Strategies
Prof. Dr. William H.R. Langridge
Center for Health Disparities and Molecular Medicine, Department of Biochemistry, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA
Prof. Dr. Kyung-Mi Lee
College of Medicine, Department of Biochemistry, Korea University Medical School, Anam-Dong 5-Ga, SungbukKu, 136-705 Seoul, South Korea
Interests: antibody-based immunotherapy; transplantation; tumor immunology; autoimmunity; NK cells; T cells; B cells
Prof. Dr. Marie-Paule Lefranc
Montpellier University, Honorary Senior Member of the University Institute of France, Chair of Immunogenetics and Immunoinformatics, IMGT® Founder and Director IMGT®, the international ImMunoGeneTics information system®, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, 141 rue de la Cardonille, 34396 Montpellier cedex 5, France
Interests: immunoglobulin; antibody engineering; antibody humanization; T cell receptor; immunoglobulin superfamily; IMGT; IMGT-ONTOLOGY
Dr. Jeanette H.W. Leusen
Immunotherapy Laboratory KC 02.085.2, Laboratory for Translational Immunology, University Medical Center, Lundlaan 6, 3584 EA Utrecht, the Netherlands
Interests: immunotherapy; antibodies and Fc receptors in cancer; autoimmunedisease and infections; mouse models
Dr. Lucia Lopalco
Immunobiology of HIV Unit, Division of Immunology, Transplantation and Infectious Diseases San Raffaele Scientific Institute, Via Stamira D'ancona 20, 20127 Milano, Italy
Interests: humoral immunity, mucosal immunity, viral-host interaction, HIV vaccines, autoimmunity
Prof. Dr. Fabienne Mackay
Department of Immunology, Faculty of Medicine, Nursing and Health Sciences Central Clinical School, Alfred Hospital, Commercial Road, Melbourne, VIC 3004, Australia
Interests: B cells; BAFF; survival; autoimmunity; toll-like receptors
Dr. Christiane Moog
Inserm Unit 1110, FMTS, Université de Strasbourg, 3 Rue de Koeberlé, F- 67000 Strasbourg, France
Interests: neutralizing antibodies; Fc mediated inhibitory antibodies; ADCC; HIV; vaccine
Prof. Dr. Yukihiro Shoyama
Professor, Faculty of Pharmaceutical Science, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan
Interests: monoclonal antibodies; bioactive compounds; marihuana study; isolation and structure elucidation; biotechnology
Contribution: Special Issue: Monoclonal Antibody Preparation against Natural Product and Its Application
Prof. Dr. Sachdev Sidhu
Terrence Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, 160 College Street, Toronto, Ontario M5S 3E1, Canada
Interests: antibody; cancer therapeuty
Prof. Dr. Arne Skerra
Institute of Biological Chemistry, Technical University Munich, Emil-Erlenmeyer-Forum 5, 85350 Freising-Weihenstephan, Germany
Interests: alternative scaffolds; antibody engineering; antibody humanization; anticalins; protein pharmacology; protein design; protein crystallography
Prof. Dr. Ronald P. Taylor
University of Virginia School of Medicine, Room 6-023 Jordan Hall, Box 800733, 1340 Jefferson Park Avenue, Charlottesville, VA 22908, USA
Interests: ADCC; CDC; complement and Fc receptors; immunotherapy of cancer; antigenic modulation
Dr. Jean-Luc Teillaud
Cordeliers Research Center/INSERM U.872, 15 rue de l'Ecole de Médecine, 75270 Paris cedex 06, France
Website: http://Website:
Interests: adaptive anti-tumor response; ADCC; Fc receptors; therapeutic antibodies
Dr. Shyam Unniraman
Department of Immunology, Duke University, Durham, NC 27710, USA
Interests: somatic hypermutation; class switch recombination; plasma cells; memory B cells; lymphoma
Prof. Dr. Nathan Wall
Center for Health Disparities and Molecular Medicine, Department of Biochemistry and Microbiology, Loma Linda University School of Medicine, Loma Linda, CA, USA
Interests: tumor microenvironment; pancreatic and childhood cancers; health disparities research; DNA damage/repair; apoptosis and inhibition of apoptosis; leukemia/lymphoma/myeloma; transcriptional regulation; tumor suppression/oncogenesis; protein complexing; cancer surveillance; tumor immunology
Prof. Dr. Tianlei Ying
Antibody Engineering and Drug Discovery Group, MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, 131 Dong An Road, Shanghai 200032, China
Interests: monoclonal antibodies; antibody engineering; Fc receptors; immunotherapy of cancer; infectious diseases
Dr. Zhixin Zhang
Department of Pathology and Microbiology, University of Nebraska Medical Center, 987660 Nebraska Medical Center, LTC 11706A, Omaha, NE 68198, USA
Website: http://Website:
Interests: V(D)J recombination; VH replacement; receptor editing; B cell antigen receptor signaling; autoantibody and autoimmunity
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert